First Trust Advisors
CGON icon

First Trust Advisors’s CG Oncology CGON Stock Holding History

First Trust Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Sell
233,517
-99,675
-30% -$6.52M 0.01% 998
2026
Q1 		$22.6M Buy
333,192
+151,394
+83% +$8.58M 0.02% 851
2025
Q4 		$7.55M Buy
181,798
+106,259
+141% +$4.4M 0.01% 1219
2025
Q3 		$3.04M Buy
+75,539
New +$2.2M ﹤0.01% 1634

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors's CGON Position: Q2 2026 in Review

First Trust Advisors reduced its CG Oncology (CGON) stake by 30% in Q2 2026, selling an estimated $6.52M and leaving 233,517 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #998.

First Trust Advisors first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. The position peaked at $22.6M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • First Trust Advisors held 233,517 shares of CG Oncology worth $16.6M as of Q2 2026.
  • First Trust Advisors sold 99,675 CG Oncology shares in Q2 2026, an estimated $6.52M.
  • CG Oncology made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #998 holding.
  • First Trust Advisors first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • First Trust Advisors's CG Oncology position peaked at $22.6M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.